Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6140958 | 6965802 | I | 6140958-6 | 20090225 | 20090316 | 20090331 | EXP | A-CH2009-24480 | ACTELION PHARMACEUTICALS US, INC. | 43 | YR | F | N | 53 | KG | 20090330 | MD | 20090309 | TAIWAN, PROVINCE OF CHINA |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6140958 | 1011367866 | PS | TRACLEER | 1 | ORAL | 125 MG, BID, ORAL; 62.5 MG, BID, | D | D | EP039P201 | 20100301 | 21290 |
| 6140958 | 1011408788 | C | WARFARIN SODIUM | 1 | |||||||
| 6140958 | 1011408789 | C | LEVOCETIRIZINE (LEVOCETERIZINE) | 2 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 6140958 | 1011367866 | PULMONARY ARTERIAL HYPERTENSION |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 6140958 | DE |
| 6140958 | HO |
| 6140958 | OT |
Reactions reported
| Event ID | PT |
|---|---|
| 6140958 | ALANINE AMINOTRANSFERASE INCREASED |
| 6140958 | ANAESTHETIC COMPLICATION |
| 6140958 | ASPARTATE AMINOTRANSFERASE INCREASED |
| 6140958 | BLOOD BILIRUBIN INCREASED |
| 6140958 | ENDOMETRIAL DISORDER |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 6140958 | FGN |
| 6140958 | HP |
| 6140958 | OTH |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 6140958 | 1011367866 | 20070712 | 20070811 | ||
| 6140958 | 1011367866 | 20070812 | 20090201 |